Description

Retatrutide – Research Grade Peptide

Description:
Retatrutide is a novel synthetic peptide and one of the first tri-agonists in the incretin class, designed to activate the GLP-1 (glucagon-like peptide-1) receptor, the GIP (glucose-dependent insulinotropic polypeptide) receptor, and the glucagon receptor (GCGR) simultaneously. By engaging these three key signaling pathways, Retatrutide represents an advanced tool for metabolic and endocrinology research, with potential to deepen scientific understanding of energy balance, glucose regulation, and obesity biology.

Research Significance:

• GLP-1 receptor activation: Investigated for effects on appetite suppression, slowed gastric emptying, glucose control, and insulin secretion.
• GIP receptor activation: Studied for complementary incretin activity, enhancing insulinotropic effects and supporting metabolic function.
• Glucagon receptor activation: Under investigation for its role in boosting energy expenditure, lipid metabolism, and thermogenesis.

Potential Applications in Research:

• Modeling multi-pathway incretin signaling in metabolic disorders.
• Studying body-weight regulation, appetite, and satiety mechanisms.
• Investigating glucose and lipid metabolism in preclinical models.
• Exploring synergistic effects of tri-agonism compared to single- or dual-pathway agonists.

Background:
Preclinical studies and early-stage human investigations suggest that Retatrutide may offer robust, dose-dependent weight reduction and improvements in glycemic parameters. As research advances, it has become a leading candidate for exploring how multi-receptor incretin agonists could transform therapeutic approaches to obesity and metabolic disease.

Specifications:

• Compound: Retatrutide (Research Grade)
• Form: Lyophilized powder
• Storage: Store at -20°C in a dry, dark place
• Stability: Stable for extended periods when properly stored

Important Notice:
This product is supplied strictly for laboratory research use only. It is not intended for human or veterinary use. No therapeutic or diagnostic claims are made.